|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.86 USD | +0.74% |
|
-0.31% | +6.94% |
| 08-07 | Haisco Pharmaceutical Gets China Clinical Trial Nod for Migraine Treatment; Shares Rise 4% | MT |
| 08-06 | RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3% | MT |
| Market Cap | 435B 376B 352B 322B 606B 41,467B 615B 4,126B 1,619B 20,745B 1,633B 1,597B 69,092B | P/E 2026 * |
31.4x | P/E 2027 * | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 495B 429B 401B 366B 690B 47,221B 701B 4,698B 1,843B 23,624B 1,859B 1,819B 78,679B | EV / Sales 2026 * |
7.33x | EV / Sales 2027 * | 6.61x |
| Free-Float |
95.71% | Yield 2026 * |
2.79% | Yield 2027 * | 2.94% |
Last Transcript: AbbVie Inc.
| 1 day | -0.46% | ||
| 1 week | -0.31% | ||
| Current month | -2.63% | ||
| 1 month | -1.50% | ||
| 3 months | +20.50% | ||
| 6 months | +9.85% | ||
| Current year | +6.94% |
| 1 week | 241.2 |  | 249.95 |
| 1 month | 241.2 | | 267.47 |
| Current year | 190.75 | | 267.47 |
| 1 year | 190.75 | | 267.47 |
| 3 years | 135.85 | | 267.47 |
| 5 years | 105.56 | | 267.47 |
| 10 years | 55.06 | | 267.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Director | 62 | 0.0000% | ||
| 30/06/26 | Free | Director | 134 | 0.0000% | ||
| 08/05/26 | Free | Director | 1,118 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.74% | -0.31% | +23.01% | +61.35% | 435B | |
| +3.82% | +8.11% | +90.85% | +132.54% | 1,057B | |
| +0.99% | +2.04% | +49.36% | +50.79% | 625B | |
| +1.58% | +5.51% | +51.42% | +40.47% | 363B | |
| +0.65% | +0.16% | +34.81% | +39.85% | 296B | |
| +0.79% | -5.08% | +9.78% | +7.23% | 249B | |
| +1.52% | +8.73% | +44.49% | +57.19% | 222B | |
| +0.34% | -0.11% | -5.23% | -51.54% | 209B | |
| -0.11% | +1.55% | +10.55% | +66.48% | 165B | |
| +1.08% | +7.97% | +9.95% | -24.34% | 153B | |
| Average | +0.78% | +3.58% | +31.90% | +38.00% | 377.33B | |
| Weighted average by Cap. | +1.04% | +4.15% | +47.79% | +62.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.58B 58.51B 54.69B 49.98B 94.18B 6,446B 95.66B 641B 252B 3,225B 254B 248B 10,740B | 73.51B 63.64B 59.48B 54.36B 102B 7,011B 104B 698B 274B 3,507B 276B 270B 11,682B |
| Net income | 13.85B 11.99B 11.21B 10.24B 19.3B 1,321B 19.61B 131B 51.58B 661B 52.01B 50.88B 2,201B | 18.9B 16.36B 15.29B 13.98B 26.34B 1,803B 26.75B 179B 70.38B 902B 70.97B 69.42B 3,004B |
| Net Debt | 60.33B 52.23B 48.82B 44.62B 84.08B 5,754B 85.4B 572B 225B 2,879B 227B 222B 9,588B | 51.47B 44.56B 41.65B 38.06B 71.73B 4,909B 72.85B 488B 192B 2,456B 193B 189B 8,179B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | $247.86 | +0.74% | 2,656,407 |
| 07/08/26 | $246.04 | +0.89% | 4,930,711 |
| 06/08/26 | $243.87 | -0.95% | 4,570,167 |
| 05/08/26 | $246.20 | +0.98% | 5,193,732 |
| 04/08/26 | $243.80 | -0.53% | 8,028,831 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
